GlassScriptPhysician profile
Paul B Lyon
NPI 1194773465
$9,499.52
in general payments reported to CMS, 2019-2025
33 companies · $2,846 in 2025
The $2,846 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,026 · 2020: $735 · 2021: $343 · 2022: $1,120 · 2023: $2,163 · 2024: $1,266 · 2025: $2,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,726 · Travel and Lodging: $1,469 · Education: $79.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,725.57 |
| Travel and Lodging | $1,469.39 |
| Education | $79.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $2,126.50 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $1,122.16 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $899.88 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $823.06 | 2019-2025 | |
| Laborie Medical Technologies Corp. | $564.59 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Neotract INC. | $549.60 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $446.09 | 2019-2025 | |
| Myovant Sciences INC. | $357.54 | 2021-2022 | |
| Abbvie INC. | $321.58 | 2022-2025 | |
| Coloplast Corp | $244.36 | 2022-2025 | Speedicath, Porges Coloplast |
| Olympus America INC. | $232.16 | 2020-2023 | Itind System |
| Boston Scientific Corporation | $197.51 | 2022-2023 | Moses 550 D\F\L |
| Teleflex LLC | $192.41 | 2021-2024 | Urolift |
| Endo Pharmaceuticals INC. | $173.57 | 2019-2023 | Edex, Xiaflex, Aveed |
| Tolmar, INC. | $160.73 | 2023-2025 | Eligard |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bluewind Medical | $133.68 | 2024 | Revi |
| Angiodynamics, INC. | $121.03 | 2025 | Nanoknife |
| Calyxo, INC. | $110.88 | 2025 | Cvac Aspiration System |
| Medtronic, INC. | $101.53 | 2023 | Interstim |
| Urovant Sciences INC | $84.57 | 2022 | |
| Progenics Pharmaceuticals, INC. | $78.24 | 2025 | |
| Sk Life Science, INC. | $70.33 | 2022 | |
| 180 Medical, INC. | $69.17 | 2022-2025 | Gentlecath Glide |
| Becton, Dickinson and Company | $62.07 | 2022 | |
| Urogen Pharma, INC. | $52.60 | 2024-2025 | |
| Antares Pharma, INC. | $41.42 | 2019-2024 | Xyosted |
| Endo USA, INC. | $34.65 | 2025 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $29.20 | 2025 | Provenge |
| Janssen Biotech, INC. | $21.96 | 2024 | Erleada |
| C. R. Bard, INC. & Subsidiaries | $20.29 | 2023 | Bard Urinary Drainage Bag |
| Cardinal Health 414 LLC | $19.89 | 2023 | |
| Lantheus Medical Imaging, INC. | $19.40 | 2024 | |
| Mission Pharmacal Company | $16.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lyon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.